bpc-157 endothelium protection BPC-157/NAD+/GUK-Cu - Peptide Patch BPC-157 Peptide: Mechanisms, Benefits, and

Elevated IGF-1 levels raise concerns about potential proliferative effects on existing malignancies, making growth hormone therapy problematic for individuals with cancer history or elevated cancer risk

PMID 19713987

Apply one change at a time

Staresinic M, Sebecic B, Patrlj L

50mg vial with 2.5ml bacteriostatic water: 50mg 2.5ml = 20mg/ml For 1mg dose: 1mg 20mg/ml = 0.05ml = 5 units on U-100 syringe 50mg vial with 2ml bacteriostatic water: 50mg 2ml = 25mg/ml For 1mg dose: 1mg 25mg/ml = 0.04ml = 4 units on U-100 syringe 100mg vial with 5ml bacteriostatic water: 100mg 5ml = 20mg/ml For 2mg dose: 2mg 20mg/ml = 0.1ml = 10 units on U-100 syringe Higher concentrations mean smaller injection volumes but require more precise syringe handling

Frozen single-use aliquots at minus 20C can extend usability to around 90 to 120 days, though potency still drops slightly each week